It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2011.
2011 | Mumbai, Maharashtra, India | ActiveDarnax Pharma Private Limited, a active private limited company, was established on 09 August 2011 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24100MH2011PTC220735. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹2.10 M and a paid-up capital of ₹2.10 M.
It upholds a compliant status. Its leadership includes Rekha Naresh Hiran (Director), Naresh Kantilal Hiran (Additional Director), Dariyadevi Kantilal Hiran (Director). Past directors included Naresh Kantilal Hiran. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1616, One Lodha Place, Senapati Bapat Marg, Lower Parel, Mumbai, Maharashtra, 400013.
U24100MH2011PTC220735
220735
09 August 2011
₹2.10 M
₹2.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Darnax Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rekha Naresh Hiran | Director | 01 Mar 2018 | Current |
| Naresh Kantilal Hiran | Additional Director | 07 Feb 2023 | Current |
| Dariyadevi Kantilal Hiran | Director | 09 Aug 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Mar 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Darnax Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 25.54% decrease. The company also saw a substantial fall in profitability, with a 66.48% decrease in profit. The company's net worth Soared by an impressive increase of 11.73%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Darnax Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Darnax Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Darnax Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Darnax Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Darnax Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Darnax Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Naresh Kantilal Hiran was appointed as a Additional Director was appointed as a Additional Director on 07 Feb 2023 & has been associated with this company since 2 years 11 months . was recorded as a recent event.
Progress on Rekha Naresh Hiran was appointed as a Director was appointed as a Director on 01 Mar 2018 & has been associated with this company since 7 years 10 months . was documented.
Progress on Dariyadevi Kantilal Hiran was appointed as a Director was appointed as a Director on 09 Aug 2011 & has been associated with this company since 14 years 5 months . was documented.
The activity Darnax Pharma Private Limited was registered on 09 Aug 2011 with Roc Mumbai & aged 14 years 5 months as per MCA records. was completed.
The CIN of Darnax Pharma Private Limited is U24100MH2011PTC220735.
Darnax Pharma Private Limited is headquartered at 1616, One Lodha Place, Senapati Bapat Marg, Lower Parel, Mumbai, Maharashtra, 400013.
Darnax Pharma Private Limited was incorporated on 09 August 2011.
The current directors of Darnax Pharma Private Limited are
The primary industry of Darnax Pharma Private Limited is Trade.
Darnax Pharma Private Limited is unlisted.
The authorized capital of Darnax Pharma Private Limited is ₹2.10 M, and the paid-up capital is ₹2.10 M.
The compliance status of Darnax Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX